Top compounds associated with response to CT47A10


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.076 0.02
mRNA BMS-754807 CTRPv2 pan-cancer AAC -0.077 0.02
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.076 0.02
mRNA Compound 23 citrate CTRPv2 pan-cancer AAC -0.074 0.02
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.078 0.02
mRNA GSK-J4 CTRPv2 pan-cancer AAC -0.24 0.03
mRNA NVP-ADW742 CTRPv2 pan-cancer AAC -0.074 0.03
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.072 0.03
mRNA bid1870 gCSI pan-cancer AAC 0.078 0.03
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.075 0.03
Download CSV